These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32721449)

  • 1. OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath.
    Awasthi A; Vishwas S; Corrie L; Kumar R; Khursheed R; Kaur J; Kumar R; Arya KR; Gulati M; Kumar B; Singh SK; Pandey NK; Wadhwa S; Kumar P; Kapoor B; Gupta RK; Kumar A
    Eur J Pharmacol; 2020 Oct; 884():173381. PubMed ID: 32721449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: Main therapeutic options.
    Hachfi W; Ben Lasfar N
    Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19: Progress in diagnostics, therapy and vaccination.
    Liu X; Liu C; Liu G; Luo W; Xia N
    Theranostics; 2020; 10(17):7821-7835. PubMed ID: 32685022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.
    Samudrala PK; Kumar P; Choudhary K; Thakur N; Wadekar GS; Dayaramani R; Agrawal M; Alexander A
    Eur J Pharmacol; 2020 Sep; 883():173375. PubMed ID: 32682788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drugs and plasma therapy used for Covid-19 treatment: a nationwide Turkish algorithm.
    Nadaroglu H
    Drug Metab Rev; 2020 Nov; 52(4):531-539. PubMed ID: 32758037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 pandemic: A review based on current evidence.
    Mahalmani VM; Mahendru D; Semwal A; Kaur S; Kaur H; Sarma P; Prakash A; Medhi B
    Indian J Pharmacol; 2020; 52(2):117-129. PubMed ID: 32565599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: an update on diagnostic and therapeutic approaches.
    Iyer M; Jayaramayya K; Subramaniam MD; Lee SB; Dayem AA; Cho SG; Vellingiri B
    BMB Rep; 2020 Apr; 53(4):191-205. PubMed ID: 32336317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 diagnosis and management: a comprehensive review.
    Pascarella G; Strumia A; Piliego C; Bruno F; Del Buono R; Costa F; Scarlata S; Agrò FE
    J Intern Med; 2020 Aug; 288(2):192-206. PubMed ID: 32348588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of SARS-CoV-2: How far have we reached?
    Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
    Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical findings in a patient with haemophilia A affected by COVID-19.
    Cui D; Zhang A; Liu A; Hu Q
    Haemophilia; 2020 Jul; 26(4):e214-e216. PubMed ID: 32239590
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiological analysis of COVID-19 and practical experience from China.
    Ye Q; Wang B; Mao J; Fu J; Shang S; Shu Q; Zhang T
    J Med Virol; 2020 Jul; 92(7):755-769. PubMed ID: 32237160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2; What We Know so far.
    Rajani HF; Alshaikh FA; Anushiravani A
    Arch Iran Med; 2020 Jul; 23(7):498-502. PubMed ID: 32657601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.
    Chakraborty C; Sharma AR; Sharma G; Bhattacharya M; Lee SS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):4016-4026. PubMed ID: 32329877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
    Gupta SP
    Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non Pharmaceutical Interventions for Optimal Control of COVID-19.
    Zamir M; Shah Z; Nadeem F; Memood A; Alrabaiah H; Kumam P
    Comput Methods Programs Biomed; 2020 Nov; 196():105642. PubMed ID: 32688137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices.
    Ardura M; Hartley D; Dandoy C; Lehmann L; Jaglowski S; Auletta JJ;
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):e147-e160. PubMed ID: 32339662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.